AIBN start-up companies

AIBN has established an enviable track record in developing products and creating companies based on AIBN technology. Start-up companies have been formed across diverse fields including drug delivery, vaccines and advanced materials.

Four start-up companies currently operate largely or exclusively out of AIBN. Institute researchers founded three companies to develop AIBN technology.

The start-up companies are distinct entities, with their own management structures, boards and finances. AIBN provides facilities, equipment and, through UQ’s commercialisation company UniQuest, a level of specialist support, such as management of patents and commercial advice. Institute researchers are intimately involved with the companies, ensuring a close connection between ongoing research within AIBN and development and commercialisation of each company’s technology.